4 European Projects Found
Searched on 125080 European Projects
FINISHED
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease (NILVAD)
Start date: Jan 1, 2012, End date: Dec 31, 2016,
Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even modest therapeutic advances that delay disease onse ...
Read Project
17
Partners Participants
FINISHED
A novel micronutrient-based strategy to prevent hearing impairments: test and road to market for age-related hearing loss and preservation of residual hearing (PROHEARING)
Start date: Jul 1, 2012, End date: Jun 30, 2016,
Hearing impairment affects 600M people worldwide. It greatly decreases quality of life, particularly in the elderly, and constitutes an unmet health and medical need. Regeneration of sensory auditory hair cells is not available as a medical technology. In concordance with this topic call, we propose a novel strategy based on the development of a new technology, a micronutrient formulation imple ...
Read Project
5
Partners Participants
FINISHED
Utilisation of the mesenchymal stem cell receptome for rational development of uniform, serum-free culture conditions and tools for cell characterization (PurStem)
Start date: Nov 1, 2008, End date: Apr 30, 2012,
Stem cells offer a promising avenue to therapy for a wide range of complaints. However, for this potential to be realized, a consistent and plentiful supply of well-characterised stem cells is essential. There has been relatively little progress in the development of new culture technologies for the large-scale manufacture of mesenchymal stem cells (MSCs). There is a strong possibility that this ...
Read Project
7
Partners Participants
FINISHED
"Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicine" (APO-SYS)
Start date: Feb 1, 2008, End date: Jan 31, 2012,
"A Europe-wide consortium of experimental biologists, biomathematicians, biostatisticians, computer scientists and clinical scientists will team up to approach cell death pathways in health and disease, placing particular emphasis on cancer and AIDS. The consortium will create a unique database integrating existing and accumulating knowledge on lethal signal transduction pathways leading to apopto ...
Read Project
